STAT

3 challenges to watch in global health in 2020

Houston, we’ve got a polio problem, will cases of the mysterious polio-like ailment spike again, and whither dengue vaccines? Here are three challenges to watch in global health in 2020.

New Year’s Day may usher in a new decade, but our crystal ball suggests some old problems will remain key global health issues in 2020.

We’re sticking out our neck a bit and leaving the long-long-long-running Ebola outbreak in the Democratic Republic of the Congo off our list of top public health stories to watch in the coming year. Call us crazy optimists — no one ever has before! — but we’re hopeful that despite recent violence in the outbreak zone, the downward trend that has accelerated in recent months means this nightmare epidemic will finally end sometime in early-ish 2020. Warning: The final few miles of the road will likely be bumpy.

So Ebola aside, what do the tea leaves tell us about the public health stories we’ll be paying attention to in 2020? Read

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks